Medicare GLP-1 Program Opens at $50 a Month Without Over-65 Safety Checks
Updated
Updated · Medical Daily · Jul 25
Medicare GLP-1 Program Opens at $50 a Month Without Over-65 Safety Checks
2 articles · Updated · Medical Daily · Jul 25
Summary
$50 monthly co-pays under Medicare’s GLP-1 Bridge Program are expanding access for older Americans, but the July 1 launch did not require age-specific screening for muscle loss, bone density, frailty or malnutrition.
Most pivotal semaglutide and tirzepatide trials studied adults with mean ages of roughly 45 to 62, while newer research shows 25% to 40% of weight lost on high-efficacy GLP-1 drugs can come from lean mass.
That gap matters most for adults over 65, among whom sarcopenia already affects about one in three over 60 and can raise risks of falls, fractures, functional decline and loss of independent living.
Geriatric specialists are urging baseline DXA, nutrition and frailty assessments, slower dosing, higher protein intake and resistance exercise, especially for frail patients 75 and older or those with osteoporosis risk.
CMS has not announced tougher monitoring rules, and the Bridge Program runs through Dec. 31, 2027, leaving patients and clinicians to add safeguards voluntarily while permanent Medicare coverage remains unsettled.